EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer
2 Visninger
administrator
07/14/23
Lyudmila Bazhenova, MD, reviews EGFR exon 20 insertions and treatments being studied in this setting, including amivantamab, osimertinib, and poziotinib.
Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive
Vis mere
Facebook kommentarer
Ingen kommentarer fundet